Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:1 Number:12 ISSN#:2564-2537
RCT
ACE Report #10870
Ace Report Cover Cannabis

Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks


How to Cite

OrthoEvidence. Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks. ACE Report. 2019;8(1):12. Available from: https://myorthoevidence.com/AceReport/Report/10870

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Sativex and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis

J Neurol. 2015 Nov;262(11):2520-7

Contributing Authors: E Houdayer A Nuara L Straffi G Comi P Rossi LN Leocani I Schiavetti U Del Carro S Amadio V Martinelli C Vila MP Sormani

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

34 patients with progressive multiple sclerosis were treated with titrated doses of Sativex (9-delta-tetrahydrocannabinol and cannabidiol oromucosal spray) or placebo in a randomly assigned order for 4 weeks each. The purpose of the study was to determine if of 9-delta-tetrahydrocannabinol and cannabidiol treatment significantly improves neurophysiological and clinical measures of spasticity, pain...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.